Who are the European Cancer Champions?

31/05/2015 - 2 minutes

 

Cancer makes no difference… Children, elderly, healthy, disabled, black, white, etc… the disease randomly selects its targets. One of the biggest challenges of the Biotech industry today, is to lead groundbreaking innovations capable of treating cancer, which also encompass each individual’s biological specificity. So who are the leading champions?

Recently, Thomson Reuters listed the 5 top Cancer Innovators in Europe

Capture d’écran 2015-05-29 à 16.55.04

 

 

 

 

 

 

 

 

 

Now, let’s take a closer look! Unsurprisingly, the major European players, such as the Swiss companies Roche and Novartis, or the French firm Sanofi, can all be found in the table. Yet, you probably noticed that not only do both French Institutes Inserm and CNRS figure in the top 5, they also rank higher than Novartis and Sanofi.

Don’t be fooled! With an 11% increase in innovation activity each year, academic and other non-corporate organizations are behind the most innovative breakthroughs regarding cancer.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!